MYNZ - MAINZ BIOMED N.V.

0.8114
-0.099   -12.152%

Share volume: 195,389
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%
$0.91
-0.10
-0.11%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
5.83%
1 Month
-14.17%
3 Months
-24.87%
6 Months
-50.52%
1 Year
-85.11%
2 Year
-16.72%
Key data
Stock price
$0.81
P/E Ratio 
0.00
DAY RANGE
$0.79 - $0.93
EPS 
N/A
52 WEEK RANGE
$0.55 - $5.54
52 WEEK CHANGE
-$85.54
MARKET CAP 
6.210 M
YIELD 
N/A
SHARES OUTSTANDING 
17.557 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
12-03-2024
NEXT EARNINGS DATE
04-29-2025
BETA 
0.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$205,049
AVERAGE 30 VOLUME 
$606,352
Company detail
CEO: Guido Baechler
Region: US
Website: mainzbiomed.com
Employees: 30
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.

Recent news